Quoin Pharmaceuticals Ltd.

QNRX | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.90

-$0.16 (-2.27%)

At close: Sep 21, 2026, 4:00 PM ET

$6.85

-$0.05 (-0.72%)

Pre-market: Sep 22, 2026, 8:37 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Quarter Period Ending	Q2 2026 Jun 29, 2026	Q1 2026 Mar 30, 2026	Q4 2025 Dec 30, 2025	Q3 2025 Sep 29, 2025	Q2 2025 Jun 29, 2025	Q1 2025 Mar 30, 2025	Q4 2024 Dec 30, 2024	Q3 2024 Sep 29, 2024	Q2 2024 Jun 29, 2024	Q1 2024 Mar 30, 2024	Q4 2023 Dec 30, 2023	Q3 2023 Sep 29, 2023	Q2 2023 Jun 29, 2023	Q1 2023 Mar 30, 2023	Q4 2022 Dec 30, 2022	Q3 2022 Sep 29, 2022	Q2 2022 Jun 29, 2022	Q1 2022 Mar 30, 2022	Q4 2021 Dec 30, 2021	Q3 2021 Sep 29, 2021	Q2 2021 Jun 29, 2021	Q1 2021 Mar 30, 2021
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	25.43K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	-25.43K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-5.57M	-5.13M	-4.52M	-4.02M	-3.79M	-3.96M	-2.41M	-2.53M	-2.14M	-2.46M	-2.22M	-2.13M	-2.26M	-2.78M	-2.09M	-2.33M	-2.67M	-2.18M	-2.98M	-1.3M	-976.89K	-801.76K
Interest Income	102.68K	146.78K	171.7K	62.27K	105.4K	144.87K	109.33K	146.39K	165.26K	137.51K	158.55K	196.43K	187.59K	152.05K	80.61K	15.13K	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	-5.46M	-5M	-4.35M	-3.95M	-3.7M	-3.81M	-2.31M	-2.35M	-1.97M	-2.33M	-2.05M	-1.93M	-2.11M	-2.6M	-2M	-3.03M	-2.67M	-1.68M	-11.82M	-1.4M	-4.34M	-3.9M
Net Income	-5.46M	-5M	-4.35M	-3.95M	-3.7M	-3.81M	-2.31M	-2.35M	-1.97M	-2.33M	-2.05M	-1.93M	-2.11M	-2.6M	-2M	-3.03M	-2.67M	-1.68M	-11.82M	-1.4M	-4.34M	-3.9M
Selling & General & Admin	1.88M	1.7M	1.42M	1.74M	1.74M	1.58M	1.33M	1.36M	1.55M	1.57M	1.39M	1.37M	1.63M	1.68M	1.47M	1.58M	1.94M	1.59M	1.97M	1.04M	737.61K	744.97K
Research & Development	3.66M	3.43M	3.1M	2.28M	2.05M	2.37M	1.07M	1.17M	587.5K	885.3K	832.39K	758.76K	625.1K	1.09M	613.07K	745.51K	726.69K	587.57K	1.01M	260K	239.28K	56.79K
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	5.54M	5.13M	4.52M	4.02M	3.79M	3.96M	2.41M	2.53M	2.14M	2.46M	2.22M	2.13M	2.26M	2.78M	2.09M	2.33M	2.67M	2.18M	2.98M	1.3M	976.89K	801.76K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	714.08K	n/a	n/a	574.13K	248.17K	202.51K	65.6K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	5.57M	5.13M	4.52M	4.02M	3.79M	3.96M	2.41M	2.53M	2.14M	2.46M	2.22M	2.13M	2.26M	2.78M	2.09M	2.33M	2.67M	2.18M	2.98M	1.3M	976.89K	801.76K
Income Tax Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	2.01M	2.83M	1.5M	588.17K	588.17K	586.33K	186.51K	5M	5.05M	2.1M	987.22K	987.22K	987.22K	987.22K	403.88K	274.37K	274.37K	55.91K	45K	20K	20K	20K
Shares Outstanding (Diluted)	2.01M	2.83M	1.5M	588.17K	588.17K	586.33K	186.51K	5M	5.05M	2.1M	987.22K	987.22K	987.22K	987.22K	403.88K	274.37K	274.37K	55.92K	45.2K	20.03K	20.03K	20.03K
EPS (Basic)	-2.72	-1.77	-2.92	-6.71	-6.28	-6.50	-12.37	-16.45	-0.39	-1.12	-2.10	-1.95	-2.13	-2.42	-4.89	-13.64	-9.72	-21.28	-476.81K	-70.21	-216.88	-195.19
EPS (Diluted)	-2.72	-1.77	-2.92	-6.71	-6.28	-6.50	-12.41	-16.45	-0.39	-1.12	-2.10	-1.95	-2.13	-2.42	-4.89	-13.64	-9.72	-21.27	-474.66K	-70.11	-216.57	-194.92
EBITDA	-5.54M	-5.12M	-4.32M	-3.92M	-3.67M	-3.79M	-2.29M	-2.32M	-1.95M	-2.3M	-2.02M	-1.9M	-2.08M	-2.58M	-1.97M	-2.29M	-2.64M	-1.66M	-11.22M	-1.13M	-4.11M	-3.81M
EBIT	-5.57M	-5.12M	-4.35M	-3.95M	-3.7M	-3.81M	-2.31M	-2.35M	-1.97M	-2.33M	-2.05M	-1.93M	-2.11M	-2.6M	-2M	-2.32M	-2.67M	-1.68M	-11.24M	-1.16M	-4.14M	-3.84M
Depreciation & Amortization	25.43K	n/a	25K	25K	25K	25K	25K	25K	25K	25K	25.67K	26.01K	26.01K	26.01K	26.01K	26.01K	26.01K	26.01K	26.01K	26.01K	26.01K	26.01K